DFP-10917

· Delta-Fly Pharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DFP-10917, covering 2019-10-25 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage [Phase 3]